Get an alert when LOOMIS PHARMA (UK) LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-11-14 (in 6mo)

Last made up 2025-10-31

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

£10K

Equity attributable

Employees

Average over period

Profit before tax

-£34

Period ending 2024-12-31

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover
Operating profit -£258-£538
Profit before tax £14-£34
Net profit £14-£34
Cash
Total assets less current liabilities £10,014£9,980
Net assets £10,014£9,980
Equity £10,014£9,980
Average employees
Wages
Directors' remuneration

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Year-on-year comparison hidden: this filing covers about 12 months versus 16 months prior.

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Return on capital employed -2.6%-5.4%

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Deloitte LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The directors are satisfied that Loomis AB has the necessary financial resources to provide support, should it be required. A letter of support has been signed by the parent company Loomis AB confirming their continuing support for a period of not less than 12 months from the date of approval to these financial statements.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 0 resigned

Name Role Appointed Born Nationality
ASLUND, Erik Daniel Director 2022-08-25 Aug 1982 Swedish
DEAR, Benjamin Michael Director 2024-02-22 Jun 1978 British
KAZES, Stephane Director 2022-08-25 Jun 1979 French

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Loomis Ab Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2022-08-25 Active

Filing timeline

Last 11 of 11 total filings

Date Type Category Description
2025-10-31 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-10-02 AA accounts Accounts with accounts type full
2025-05-01 AD01 address Change registered office address company with date old address new address PDF
2025-01-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-05-29 AA accounts Accounts with accounts type full
2024-02-22 AP01 officers Appoint person director company with name date PDF
2024-02-21 AD01 address Change registered office address company with date old address new address PDF
2024-01-03 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-01-04 CS01 confirmation-statement Confirmation statement with updates PDF
2022-09-13 AA01 accounts Change account reference date company current extended PDF
2022-08-25 NEWINC incorporation Incorporation company PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
3

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page